Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function (Q31895027)

4 July 2017

title

Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function (English)

1 reference

4 July 2017

1 reference

0 references

6

Banerji MA

1 reference

4 July 2017

5

Lebovitz HE

1 reference

4 July 2017

McFarlane SI

1

1 reference

4 July 2017

Chaiken RL

series ordinal

2

1 reference

4 July 2017

Hirsch S

series ordinal

3

1 reference

4 July 2017

Harrington P

series ordinal

4

1 reference

4 July 2017

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

18

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

10-16

1 reference

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Ketoacidosis-onset type 2 diabetes in Japanese. Association with the widespread distribution of soft drinks and vending machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Long-term normoglycemic remission in black newly diagnosed NIDDM subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Insulin action in black Americans with NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Trial of placebo in long-term chlorpropamide-treated diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00395.X

10.1046/J.1464-5491.2001.00395.X

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference